- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/64 - General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
Patent holdings for IPC class C12N 15/64
Total number of patents in this class: 1079
10-year publication summary
|
78
|
61
|
66
|
65
|
84
|
106
|
68
|
71
|
87
|
15
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shenzhen Biocan Technologies Co., Ltd. | 147 |
22 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
18 |
| The Regents of the University of California | 18943 |
16 |
| Generation Bio Co. | 119 |
15 |
| Aldevron, L.L.C. | 69 |
14 |
| The Johns Hopkins University | 5377 |
13 |
| ZymoGenetics, LLC | 20 |
13 |
| President and Fellows of Harvard College | 5792 |
11 |
| ZymoGenetics, Inc. | 244 |
10 |
| Massachusetts Institute of Technology | 9795 |
9 |
| The Trustees of the University of Pennsylvania | 4122 |
9 |
| Orna Therapeutics, Inc. | 36 |
8 |
| Telesis Bio Inc. | 56 |
8 |
| DSM IP Assets B.V. | 5856 |
7 |
| Life Technologies Corporation | 3068 |
7 |
| F. Hoffmann-La Roche AG | 7958 |
6 |
| BASF SE | 19740 |
6 |
| Agilent Technologies, Inc. | 2744 |
6 |
| Cellectis | 397 |
6 |
| Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences | 1478 |
6 |
| Other owners | 869 |